FICKENSCHER JAMES E (Chief Financial Officer) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/28/2022ACC: 0001062993-22-001785
Officer· Chief Financial Officer
Since Aug 2018
+210K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
210K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+85K
Price / share
—
Trade value
—
% of position
116.9%
1/26/2022
72.72K→157.72K
Total
Net shares
+85K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/26/2022 | A · Award | +85K | — | — | 116.9% | 72.72K | 157.72K |
| Total | +85K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
125K shares
Shares
+125K
Strike price
2.41
Held after
125K
Exercisable
—
1/26/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock125K shares | 1/26/2022 | A · Award | +125K | 2.41 | — | 125K |